| Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality TL Jørgensen, J Hallas, S Friis, J Herrstedt British journal of cancer 106 (7), 1353-1360, 2012 | 309 | 2012 |
| Comorbidity and survival after early breast cancer. A review LH Land, SO Dalton, TL Jørgensen, M Ewertz Critical reviews in oncology/hematology 81 (2), 196-205, 2012 | 127 | 2012 |
| Risk of colorectal cancer and other cancers in patients with gall stones. C Johansen, WH Chow, T Jørgensen, L Mellemkjaer, G Engholm, ... Gut 39 (3), 439-443, 1996 | 86 | 1996 |
| Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients TL Jørgensen, S Teiblum, M Paludan, LØ Poulsen, AYS Jørgensen, ... Gynecologic oncology 127 (2), 367-374, 2012 | 83 | 2012 |
| Polypharmacy and drug use in elderly Danish cancer patients during 1996 to 2006 TL Jorgensen, J Herrstedt, S Friis, J Hallas Journal of geriatric oncology 3 (1), 33-40, 2012 | 74 | 2012 |
| Long‐term use of metformin and colorectal cancer risk in type II diabetics: a population‐based case–control study M Cardel, SM Jensen, A Pottegård, TL Jørgensen, J Hallas Cancer medicine 3 (5), 1458-1466, 2014 | 64 | 2014 |
| Quality of life in patients with cancer during the COVID-19 pandemic–a Danish cross-sectional study (COPICADS) SS Jeppesen, KK Bentsen, TL Jørgensen, HS Holm, L Holst-Christensen, ... Acta Oncologica 60 (1), 4-12, 2021 | 62 | 2021 |
| The impact of comprehensive geriatric assessment for optimal treatment of older patients with cancer: A randomized parallel-group clinical trial S Nadaraja, LE Matzen, TL Jørgensen, L Dysager, AØ Knudsen, ... Journal of geriatric oncology 11 (3), 488-495, 2020 | 54 | 2020 |
| Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study B Bjørnhart, KH Hansen, TL Jørgensen, J Herrstedt, T Schytte Acta Oncologica 58 (7), 953-961, 2019 | 49 | 2019 |
| Comorbidity and polypharmacy in elderly cancer patients: the significance on treatment outcome and tolerance TL Jørgensen, J Hallas, LH Land, J Herrstedt Journal of geriatric oncology 1 (2), 87-102, 2010 | 42 | 2010 |
| The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian cancer TL Jørgensen, J Herrstedt Journal of geriatric oncology 11 (4), 593-602, 2020 | 36 | 2020 |
| Clopidogrel–Paclitaxel Drug–Drug Interaction: A Pharmacoepidemiologic Study K Agergaard, M Mau‐Sørensen, TB Stage, TL Jørgensen, RE Hassel, ... Clinical Pharmacology & Therapeutics 102 (3), 547-553, 2017 | 32 | 2017 |
| Impact of age, comorbidity, and FIGO stage on treatment choice and mortality in older danish patients with gynecological cancer: a retrospective register-based cohort study S Nadaraja, TL Jørgensen, LE Matzen, J Herrstedt Drugs-real world outcomes 5, 225-235, 2018 | 26 | 2018 |
| Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer FO Larsen, P Pfeiffer, D Nielsen, K Skougaard, C Qvortrup, K Vistisen, ... Acta Oncologica 50 (4), 574-577, 2011 | 15 | 2011 |
| Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example SB Winther, TL Jørgensen, P Pfeiffer, C Qvortrup ESMO open 1 (3), e000021, 2016 | 13 | 2016 |
| Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer C Qvortrup, BV Jensen, TL Jorgensen, D Nielsen, JK Bjerregaard, ... Acta Oncologica 49 (6), 833-836, 2010 | 13 | 2010 |
| Patient preferences for discussing life expectancy: a systematic review E Bjørk, W Thompson, J Ryg, O Gaardboe, TL Jørgensen, C Lundby Journal of General Internal Medicine 36 (10), 3136-3147, 2021 | 11 | 2021 |
| Predictive value of geriatric oncology screening and geriatric assessment of older patients with cancer: a randomized clinical trial protocol (PROGNOSIS-RCT) AKW Giger, HM Ditzel, TL Jørgensen, HJ Ditzel, A Mohammadnejad, ... Journal of Geriatric Oncology 13 (1), 116-123, 2022 | 8 | 2022 |
| Predictive value of geriatric oncology screening and geriatric assessment in older patients with solid cancers: protocol for a Danish prospective cohort study (PROGNOSIS-G8) HM Ditzel, AKW Giger, CM Lund, HJ Ditzel, A Mohammadnejad, P Pfeiffer, ... Journal of Geriatric Oncology 12 (8), 1270-1276, 2021 | 8 | 2021 |
| End-of-life anticancer treatment–a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies TO Mattsson, A Pottegård, TL Jørgensen, A Green, M Bliddal Acta oncologica 60 (8), 961-967, 2021 | 8 | 2021 |
